CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
+2.79%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$125M
AUM Growth
+$125M
(-4%)
Cap. Flow
-$8.19M
Cap. Flow
% of AUM
-6.52%
Top 10 Holdings %
Top 10 Hldgs %
68.49%
Holding
29
New
7
Increased
6
Reduced
7
Closed
9
Top Buys
| 1 |
Cigna
CI
|
$9.23M |
| 2 |
Thermo Fisher Scientific
TMO
|
$9.08M |
| 3 |
Gilead Sciences
GILD
|
$8.78M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$5.57M |
| 5 |
Biogen
BIIB
|
$4.1M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
$10.3M |
| 2 |
Hologic
HOLX
|
$9.42M |
| 3 |
Puma Biotechnology
PBYI
|
$6.5M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$6.08M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$5.3M |
Sector Composition
| 1 | Healthcare | 97.21% |
| 2 | Consumer Discretionary | 2.79% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Intuitive Surgical
ISRG
$167B
| $9.74M | 7.76% |
23,588
+1,588
| +7% | +$656K |
|
2
Illumina
ILMN
$15.5B
| $9.33M | 7.44% |
39,478
-7,722
| -16% | -$1.83M |
|
|
3
Cigna
CI
$80.3B
| $9.23M | 7.35% |
+55,000
| New | +$9.23M |
|
|
4
Biogen
BIIB
$20.3B
| $9.12M | 7.27% |
33,296
+14,975
| +82% | +$4.1M |
|
|
5
Thermo Fisher Scientific
TMO
$184B
| $9.08M | 7.24% |
+44,000
| New | +$9.08M |
|
|
6
Gilead Sciences
GILD
$140B
| $8.78M | 7% |
+116,506
| New | +$8.78M |
|
7
Vertex Pharmaceuticals
VRTX
$103B
| $8.52M | 6.79% |
52,244
-10,047
| -16% | -$1.64M |
|
8
Stryker
SYK
$149B
| $8.37M | 6.67% |
52,009
+12,009
| +30% | +$1.93M |
|
9
Molina Healthcare
MOH
$9.93B
| $7.58M | 6.04% |
93,382
+46,382
| +99% | +$3.77M |
|
10
DaVita
DVA
$9.75B
| $6.21M | 4.95% |
94,126
-46,674
| -33% | -$3.08M |
|
11
Amicus Therapeutics
FOLD
$2.4B
| $5.65M | 4.5% |
375,370
-82,247
| -18% | -$1.24M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.57M | 4.44% |
+50,000
| New | +$5.57M |
|
13
Zoetis
ZTS
$67.8B
| $4.65M | 3.71% |
55,691
-1,027
| -2% | -$85.8K |
|
|
NUVA
14
DELISTED
NuVasive, Inc.
NUVA
| $4.57M | 3.64% |
87,569
+18,289
| +26% | +$955K |
|
15
Edwards Lifesciences
EW
$48.1B
| $4.21M | 3.35% |
30,158
-27,852
| -48% | -$3.89M |
|
|
CLVS
16
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.75M | 2.99% |
71,092
+34,548
| +95% | +$1.82M |
|
17
Service Corp International
SCI
$11B
| $3.5M | 2.79% |
92,796
-1,698
| -2% | -$64.1K |
|
18
Heron Therapeutics
HRTX
$204M
| $2.98M | 2.38% |
+108,000
| New | +$2.98M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $2.51M | 2% |
+28,100
| New | +$2.51M |
|
|
ARRY
20
DELISTED
Array Biopharma Inc
ARRY
| $2.15M | 1.71% |
+131,418
| New | +$2.15M |
|
|
21
Hologic
HOLX
$14.8B
| – | – |
-220,240
| Closed | -$9.42M |
|
|
22
Puma Biotechnology
PBYI
$260M
| – | – |
-65,742
| Closed | -$6.5M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-78,132
| Closed | -$4.67M |
|
|
ADMS
24
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| – | – |
-77,517
| Closed | -$2.63M |
|
|
PTLA
25
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| – | – |
-59,149
| Closed | -$2.88M |
|